February 06, 2008 – Teva Pharmaceuticals is pleased to announce the introduction and availability of Alendronate Sodium Tablets. This product is AB rated and bioequivalent to Fosamax®* Tablets. Alendronate Sodium Tablets are available in 5 mg, 10 mg, 35 mg, 40 mg, and 70 mg strengths.
“Our customers count on Teva for a continuous supply of new generic products,” states John Denman, V.P. Sales and Marketing. “With the launch of Alendronate Sodium Tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”
Teva Pharmaceuticals, located in North Wales, Pennsylvania, is the leading pharmaceutical manufacturer for both new and total prescriptions.‡ The company has an aggressive Research and Development effort and one of the best overall ANDA approval records in the industry.
No comments:
Post a Comment